icon-folder.gif   Conference Reports for NATAP  
 
  EACS - 12th European AIDS Conference
November 11-14, 2009
Cologne, Germany
Back grey_arrow_rt.gif
 
 
 
Twice Daily Darunavir to Replace Dual Boosted Protease Inhibitors in Virologically Suppressed Patients
 
 
  Reported by Jules Levin
EACS Nov 13 2009, Cologne, Germany

image002.gif

image004.gif

image006.gif

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

* VF: HIV RNA = 446 c/mL; repeat VL = 10800 c/mL. Resistance test showed full susceptibility to all ARVs in regimen; repeat VL after resuming same regimen = 73 c/mL
 
I think I recall Cal Cohen saying lipids were normal at baseline

image020.gif

image022.gif